|
|
| Titles |
1993 APPAL Somit |
| Related Item |
|
| Genre |
medicine |
| Identifier |
Acta Latin America 016.JPG |
| Note |
Zolpidem Gador. Somit. Hypnotic selectivity. The class of the future…today. The chemical class of the future. Somit (Zolpidem Gador) selectively joins itself with the Omega-1 receptors, being the first hypnotic selective agent that is not a benzodiazepine. Somit (Zolpidem Gador) re-establishes the architecture of sleep: it does not diminish and actually promotes the paradoxical sleep (REM). Conserves or augments the duration of deep sleep. Somit (Zolpidem Gador) respects the cognitive functions, particularly attention and memory. Somit (Zolpidem Gador) does not induce residual effects or alterations of motor activity and physical performance. Somit (Zolpidem Gador) does not develop tolerance, rebound syndrome or abstinence syndrome. |
| Abstract |
Zolpidem, Gador, Box of Somit shown with tablets, along with a depiction of chemical models. |
